GSK's 3-in-1 inhaler for COPD arrives in Korea < Pharma < Article - KBR
Lupin plans to take on GSK's Advair and Forest Labs's Aerochamber in the US
GlaxoSmithKline Has Developed a Broad Respiratory Portfolio
Case study 9 – The GlaxoSmithKline Diskus inhaler - Engineering Better Care
GSK launches once-daily inhaler for asthma patients » Capital News
Ellipta - My Ellipta | GSK Pharma UK | Public Site
GlaxoSmithKline Launches New Program to Help Consumers Recycle Empty GSK Respiratory Inhalers
GSK Lawsuit Over Asthma Inhalers | RT
GSK pumping out millions more Ellipta inhalers with new U.K. plant | Fierce Pharma
GSK ventures into connected inhaler space with Propeller Health deal | MobiHealthNews
GSK's Relvar Ellipta comes out on top in real world study
Asthma Devices Market Analysis 2018 | Global Size, Share Estimation by GlaxoSmithKline plc., 3M, Baxter etc. till 2023 | Medgadget
Propeller gets FDA clearances to improve adherence to inhalers from Boehringer, GSK | MobiHealthNews
GSK fails in purple inhaler passing off claim against Sandoz and Vectura (...and breathe) - The IPKat
GSK expands its portfolio of medicines in the US for patients with asthma and COPD
GSK pumping out millions more Ellipta inhalers with new U.K. plant | Fierce Pharma
Can Switching Inhalers Reduce Your Carbon Footprint? | MedPage Today
What are the different types of inhalers? - My Pharmacy
Ventolin Inhaler GSK Prevent Bronchospasm and Obstructive Airway Disease
RECALL: Ventolin Diskus inhalers - Today's Parent
RECALL ALERT: GlaxoSmithKline Recalling 600,000 Inhalers - Julie's Freebies
GSK expands its portfolio of medicines in the US for patients with asthma and COPD
GSK Pharmaceuticals Ltd. Ventorlin Inhaler at Rs 106.93/packet in Pune | ID: 6856988391
